Stanford-StartX Fund has returned to pump funding into electric skateboard manufacturer Boosted, helping to take the company’s total funding to $70m.

Immunotherapy spinout Annexon Biosciences collected funding from Novartis Venture Fund in a series C round that brought its total funding to $154m.

MRL Ventures Fund and Roche Fund have taken part in the intracellular drug developer's series A, which is commercialising research by Prof Dehua Pei at OSU.

Synspective has been backed by a University of Tokyo VC vehicle in its bid to launch a constellation of 25 small Earth observation satellites powered by synthetic aperture radar.

Foresite Capital and F-Prime Capital joined earlier series B investors including Oxford Science Innovations to take Oxford drug discovery spinout Genomics’ total funding to $58.2m.

The MIT Media Lab customer call analytics spinout has now raised $45m for a series C round featuring investors including Salesforce Ventures, Avaya and Hearst Ventures.

Synthetic silk developer Spiber spun out of Keio University in 2007 and has now raised a total of more than $260m.

IP Group and its Venture Fund II have pumped more cash into Bristol's haptics technology developer Ultrahaptics to take the spinout’s total to $84.3m.

Karolinska Institute-founded anti-cancer therapy developer Aprea Therapeutics has now raised more than $100m of funding.

Wind turbine producer Goldwind returned and 36Kr Fund also invested as Tsinghua's rocket technology developer LandSpace secured $43.2m in a series B-plus round.